Blackbarn Capital Partners LP is an SEC-registered investment adviser based in New York, NY that reports managing 1 hedge fund on Form ADV. It reports $1.2 billion in regulatory assets under management. Its private funds, of all types, hold $1.2 billion in gross assets. Its disclosed U.S. stock holdings returned an estimated +33.3% 2026 YTD through Jun 30 (S&P 500: +9.5%), based on 13F filings. Over a longer period they returned an estimated +91.5% from Q3 2024 to Q2 2026, compared with +37.2% for the S&P 500, based on 13F filings.
- Regulatory assets under management
- $1.2 billionForm ADV Item 5.F
- Gross assets of private funds
- $1.2 billionAll private fund types, Form ADV
- Hedge funds managed
- 11 private funds in total
- Employees
- 11Form ADV Item 5.A
- Registration
- SEC-registered adviserCRD 319137
- Latest Form ADV
- 03/20/2026Disciplinary disclosures: none reported
Estimated 13F portfolio performance
Estimated by AltMountain, derived from the firm’s public Form 13F filings. Not reported by the firm and not the return of any fund.
| Quarter | Est. 13F return | S&P 500 |
|---|---|---|
| Q2 2026 | +26.8% | +14.8% |
| Q1 2026 | +5.2% | -4.6% |
| Q4 2025 | +16.6% | +2.4% |
| Q3 2025 | +18.7% | +7.8% |
| Q2 2025 | +2.5% | +10.4% |
| Q1 2025 | -5.1% | -4.5% |
| Q4 2024 | -5.6% | +2.1% |
| Q3 2024 | +13.2% | +5.4% |
Estimate of the firm's disclosed long U.S. stock portfolio from its quarterly 13F filings, holding each quarter-end portfolio to the next quarter-end at prices implied by all 13F filers. It is a price return before dividends and fees, ignores shorts, options, bonds, cash and trading within the quarter, and is not the return of any fund. Disclosures
Manager of this firm? Report your fund’s actual net return, or email hello@altmountain.com to correct or remove this estimate. Removal requests from the firm are honored.
13F holdings as of Sep 30, 2026
All 18 share positions ($509,722,910) reported by BlackBarn Capital Partners LP on Form 13F for the quarter ended Sep 30, 2026, filed Nov 16, 2026. Shown as filed with the SEC. Original filing on SEC.gov ↗ The estimated return above runs through Jun 30, 2026; it is updated when the SEC publishes its complete data for the quarter.
Share of the reported 13F portfolio, ten largest positions
- Azul S A30.59%
- Privia Health Group Inc9.44%
- Roivant Sciences LTD9.37%
- Diversified Healthcare TR7.30%
- Nextpower Inc6.15%
- NXP Semiconductors N V5.84%
- Nextera Energy Inc5.77%
- Thermo Fisher Scientific Inc4.43%
- Mcgraw Hill Inc4.23%
- Viking Therapeutics Inc3.98%
| Stock | Value | % of 13F portfolio | Shares | Shares vs prior quarter |
|---|---|---|---|---|
| Azul S A | $155,905,380 | 30.59% | 17,342,089 | +929.70% |
| Privia Health Group Inc | $48,115,100 | 9.44% | 1,870,000 | +17.98% |
| Roivant Sciences LTD | $47,776,500 | 9.37% | 1,350,000 | -32.50% |
| Diversified Healthcare TR | $37,200,000 | 7.30% | 4,000,000 | -1.84% |
| Nextpower Inc | $31,333,820 | 6.15% | 263,000 | New |
| NXP Semiconductors N V | $29,789,180 | 5.84% | 106,000 | +17.78% |
| Nextera Energy Inc | $29,402,950 | 5.77% | 335,000 | Unchanged |
| Thermo Fisher Scientific Inc | $22,561,200 | 4.43% | 45,000 | New |
| Mcgraw Hill Inc | $21,544,250 | 4.23% | 2,275,000 | -7.14% |
| Viking Therapeutics Inc | $20,285,200 | 3.98% | 520,000 | -13.33% |
| CSW Industrials Inc | $13,915,000 | 2.73% | 50,000 | New |
| Occidental Pete Corp | $12,142,500 | 2.38% | 250,000 | Unchanged |
| Venture Global Inc | $11,130,000 | 2.18% | 1,000,000 | -42.86% |
| Arbutus Biopharma Corp | $10,632,000 | 2.09% | 2,215,000 | -11.40% |
| Expand Energy Corporation | $10,486,850 | 2.06% | 115,000 | New |
| Cogent Comm Holdings Inc | $3,470,000 | 0.68% | 250,000 | Unchanged |
| Vivid Seats Inc | $3,260,000 | 0.64% | 500,000 | Unchanged |
| Iperionx LTD | $772,980 | 0.15% | 26,000 | New |
Changes since Jun 30, 2026
Comparing the share counts in the two quarter-end filings: 5 new positions, 4 sold out, 3 increased, 6 reduced and 4 unchanged.
Number of positions (a count, not dollars)
- New positions5
- Increased3
- Unchanged4
- Reduced6
- Sold out4
New positions
| Stock | Value | Shares |
|---|---|---|
| Nextpower Inc | $31,333,820 | 263,000 |
| Thermo Fisher Scientific Inc | $22,561,200 | 45,000 |
| CSW Industrials Inc | $13,915,000 | 50,000 |
| Expand Energy Corporation | $10,486,850 | 115,000 |
| Iperionx LTD | $772,980 | 26,000 |
Sold out
| Stock | Value at Jun 30, 2026 | Shares held then |
|---|---|---|
| Niq Global Intelligence PLC | $27,151,110 | 2,903,862 |
| Unitedhealth Group Inc | $27,015,950 | 65,000 |
| Amneal Pharmaceuticals Inc | $22,503,000 | 1,300,000 |
| California Res Corp | $9,252,250 | 175,000 |
Largest increases
| Stock | Change in shares | Change | Value now | Shares now |
|---|---|---|---|---|
| Azul S A | +15,657,901 | +929.70% | $155,905,380 | 17,342,089 |
| Privia Health Group Inc | +285,000 | +17.98% | $48,115,100 | 1,870,000 |
| NXP Semiconductors N V | +16,000 | +17.78% | $29,789,180 | 106,000 |
Largest reductions
| Stock | Change in shares | Change | Value now | Shares now |
|---|---|---|---|---|
| Roivant Sciences LTD | -650,000 | -32.50% | $47,776,500 | 1,350,000 |
| Venture Global Inc | -750,000 | -42.86% | $11,130,000 | 1,000,000 |
| Viking Therapeutics Inc | -80,000 | -13.33% | $20,285,200 | 520,000 |
| Mcgraw Hill Inc | -175,000 | -7.14% | $21,544,250 | 2,275,000 |
| Arbutus Biopharma Corp | -285,000 | -11.40% | $10,632,000 | 2,215,000 |
| Diversified Healthcare TR | -75,000 | -1.84% | $37,200,000 | 4,000,000 |
Each list shows up to 20 positions, largest first by dollar amount. Changes compare two quarter-end snapshots, with the earlier share count adjusted for stock splits AltMountain detected. They do not show when, or at what price, anything was bought or sold.
From public Form 13F filings, not verified. Form 13F is filed up to 45 days after the quarter ends, so positions may have changed. It lists only certain long positions in U.S.-listed stocks and exchange-traded funds; options are not shown here, and short positions, most bonds, cash, non-U.S. securities and private investments are not reported at all, so a holding may be one side of a hedge. A filing covers the manager as a whole, not any single fund, and filings contain errors. This is not investment advice or a recommendation to buy or sell any security. Disclosures
Large ownership stakes (Schedule 13D and 13G)
| Company | Filing | Percent of class | Shares | Filed | Source |
|---|---|---|---|---|---|
| Azul SA | 13G amendment | 9.6% | 35,653,514 | Nov 16, 2026 | SEC.gov ↗ |
A firm files Schedule 13G (passive) or 13D (it may seek to influence the company) when it beneficially owns more than 5% of a class of a public company's shares. Each row is the firm's latest such filing for that company since Nov 16, 2026, exactly as filed, and counts shares held across the firm and its affiliates, not by any single fund. An amendment can report a stake that has fallen below 5%. Holdings may have changed since the filing date. Not verified by AltMountain. Source: U.S. Securities and Exchange Commission, EDGAR.
Private funds reported on Form ADV (1)
As reported in the adviser's Form ADV filed Mar 12, 2024. Funds also listed from Form D are shown above.
From SEC filings. Firm data comes from the SEC's Form ADV data as of Oct 2, 2026; performance estimates come from Form 13F. AltMountain has not verified this information, and it is not an offer, solicitation or recommendation. Full disclosures